Bronstein, Gewirtz & Grossman, LLC Notifies Phathom Pharmaceuticals, Inc. (PHAT) Investors of Investigation
ACCESSWIRE
04 Aug 2022, 02:37 GMT+10
NEW YORK, NY / ACCESSWIRE / August 3, 2022 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers Phathom Pharmaceuticals, Inc. ('Phathom' or 'the Company') (NASDAQ:PHAT). Investors who purchased Phathom shares are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/phat.
The investigation concerns whether Phathomviolated federal securities laws.
On August 2, 2022, Phathom issued a press release titled: 'Phathom Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Updates,' which announced that 'we detected trace levels of a nitrosamine in vonoprazan drug product in our post-approval testing as we prepared for commercial launch.' The release continues that based on this detection, 'the Company is working with the FDA and plans to obtain approval of and implement an additional test method, specification, including a proposed acceptable intake limit, and additional controls to address this impurity prior to releasing our first vonoprazan-based products to the market.' Phathom said that 'these additional activities will result in a delay of the planned VOQUEZNA DUAL PAK and VOQUEZNA TRIPLE PAK product launches.' Following this news, Phathom stock dropped almost 29% on that same day.
If you are aware of any facts relating to this investigation or purchased Phathom shares, you can assist this investigation by visiting the firm's site: www.bgandg.com/phat. You can also contact Peretz Bronstein or law clerk and client relations manager, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC represents investors in securities fraud class actions and shareholder derivative suits. The firm has recovered hundreds of millions of dollars for investors nationwide. Attorney advertising. Prior results do not guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Nathanson
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com:
https://www.accesswire.com/710729/Bronstein-Gewirtz-Grossman-LLC-Notifies-Phathom-Pharmaceuticals-Inc-PHAT-Investors-of-Investigation
Subscribe and Follow
Get a daily dose of North Carolina Daily news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
News RELEASES
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to North Carolina Daily.
More Information
78
℉
US retailers say following shortages, baby formula return to shelves
NEW YORK CITY, New York: Months after the U.S. faced acute shortages of baby formula, this week two major U.S. ...
Hedge fund Third Point buys Disney stake, says ESPN should be sold
NEW YORK CITY, New York: The American hedge fund Third Point has purchased a stake worth some $1 billion in ...
U.S. stock markets tread water as greenback takes center stage
NEW YORK, New York - Investors were divided on Thursday as to where to send U.S. stocks. Jitters about inflation, ...
U.,S. stocks back on the defensive, Nasdaq drops 164 points
NEW YORK, New York - U.S. industrial stocks interrupted their five-day rally on Wednesday with all the major indices losing ...
U.S. stocks have mixed day, Nasdaq Composite slides 26 points
NEW YORK, New York - Stocks were decidedly mixed in the U.S. on Tuesday as investors struggled to make a ...
Covid tests for vaccinated passengers dropped by cruise lines
MIAMI, Florida: Carnival cruise lines, including Carnival Cruise, Princess Cruises and Cunard, have made plans to drop mandatory COVID-19 testing ...
US retailers say following shortages, baby formula return to shelves
NEW YORK CITY, New York: Months after the U.S. faced acute shortages of baby formula, this week two major U.S. ...
US approves sale of hearing aids without medical prescriptions
WASHINGTON D.C.: The U.S. Food and Drug Administration has approved the sale of over-the-counter hearing aids for people with mild ...
Would a new Cold War be in the best interest of the United States?
As China unleashed live-fire military exercises off the coast of Taiwan, simulating a real "reunification by force" operation in the ...
Covid tests for vaccinated passengers dropped by cruise lines
MIAMI, Florida: Carnival cruise lines, including Carnival Cruise, Princess Cruises and Cunard, have made plans to drop mandatory COVID-19 testing ...
California seeks $1.4 billion to keep nuclear plant open
SACRAMENTO, California: California Governor Gavin Newsom is proposing to give a $1.4 billion government loan to extend the life of ...
US ends Covid restrictions, cites 95% have vaccines or immunity
NEW YORK CITY, New York: The Centers for Disease Control and Prevention relaxed its COVID-19 guidelines last week, driven by ...
